Market revenue in 2023 | USD 21.8 million |
Market revenue in 2030 | USD 25.2 million |
Growth rate | 2.1% (CAGR from 2023 to 2030) |
Largest segment | Treatment |
Fastest growing segment | Treatment |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnosis, Treatment |
Key market players worldwide | AMETEK Inc, Boehringer Ingelheim, Merck & Co Inc, Zoetis Inc Class A, Dechra Pharmaceuticals, Sandoz Group AG ADR, Ceva Santé Animale, Bausch & Lomb Corp, Alcon Inc, Baxter International Inc, IRIDEX Corp, IDEXX Laboratories Inc, LKC Technologies, Inc. (LKC), Optomed |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary eye care market will help companies and investors design strategic landscapes.
Treatment was the largest segment with a revenue share of 59.17% in 2023. Horizon Databook has segmented the Norway veterinary eye care market based on diagnosis, treatment covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway veterinary eye care market , including forecasts for subscribers. This country databook contains high-level insights into Norway veterinary eye care market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account